Patents by Inventor Els Torreele

Els Torreele has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant phages capable of entering host cells via specific interaction with an artificial receptor
    Publication number: 20030165877
    Abstract: The invention relates to a genetically modified bacteriophage, pseudovirion or phagemid capable of entering a host cell by binding of its artificial ligand to an artificial receptor present on said host cell. The invention relates also to the use of the genetically modified bacteriophage, pseudovirion or phagemid and of the host cell to screen sequence libraries, including antibody library.
    Type: Application
    Filed: March 22, 2002
    Publication date: September 4, 2003
    Inventors: Serge Muyldermans, Karen Silence, Jan Steyaert, Els Torreele
  • Recombinant phages capable of entering host cells via specific interaction with an artificial receptor
    Publication number: 20030148508
    Abstract: The invention relates to a genetically modified bacteriophage, pseudovirion or phagemid capable of entering a host cell by binding of its artificial ligand to an artificial receptor present on said host cell. The invention relates also to the use of the genetically modified bacteriophage, pseudovirion or phagemid and of the host cell to screen sequence libraries, including antibody library.
    Type: Application
    Filed: September 19, 2002
    Publication date: August 7, 2003
    Applicant: VLAAMS INTERUNIVERSITAIR INSTITUUT VOOR BIOTECHNOLOGIE VZW, a Belgium corporation
    Inventors: Serge Muyldermans, Jan Steyaert, Karen Silence, Els Torreele
  • Recombinant phages capable of entering host cells via specific interaction with an artificial receptor
    Patent number: 6479280
    Abstract: The invention relates to a genetically modified bacteriophage, pseudovirion or phagemid capable of entering a host cell by binding of its artificial ligand to an artificial receptor present on said host cell. The invention relates also to the use of the genetically modified bacteriophage, pseudovirion or phagemid and of the host cell to screen sequence libraries, including antibody library.
    Type: Grant
    Filed: November 3, 1999
    Date of Patent: November 12, 2002
    Assignee: Vlaams Interuniversitair Institutuut voor Biotechnologie VZW
    Inventors: Serge Muyldermans, Jan Steyaert, Karen Silence, Els Torreele